Given the central role of JAK/STAT signaling in mediating inflammation and bone resorption, several therapeutic approaches have been developed to modulate this pathway in periodontitis (Fig. 13).JAK inhibitors (JAKi) are small molecules that block JAK activation and subsequent STAT phosphorylation. The gene discussed is SOAT1; the disease is periodontitis.